跳至主要内容
临床试验/NCT03337425
NCT03337425已完成不适用

Psychoeducational Groups for Adults With Attention-Deficit Hyperactivity/Impulsivity Disorder (ADHD): a Randomized Waitlist-controlled Multicenter Pilot Trial

Norwegian University of Science and Technology2 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2017年11月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
46
试验地点
2
主要终点
Change in patient satisfaction

研究概览

简要总结

This pilot study aims to assess patient satisfaction and preliminary efficacy of a psychoeducational group treatment, using a randomized waitlist-controlled trial, at two different outpatient clinics in mid-Norway. All participants will receive standard treatment during the intervention period. Assessment of client satisfaction (CSQ 8), general self-efficacy (GSE-6), ADHD-related quality of life (AAQoL) symptoms of ADHD (SCL-9; ASRS), and work participation will be conducted at time of recruitment prior to randomization (T0), pre- (T1), post-treatment (T2), with a 10 week follow-up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 67 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •confirmed ADHD diagnosis
  • •speaking a Scandinavian language

排除标准

  • •not able or willing to give informed consent
  • •psychosis
  • •severe learning difficulties

研究组 & 干预措施

psychoeducational groups

Experimental

Psychoeducational group therapy and standard treatment (ADHD treatment as usual)

干预措施: Psychoeducational group therapy (Behavioral)

psychoeducational groups

Experimental

Psychoeducational group therapy and standard treatment (ADHD treatment as usual)

干预措施: Standard treatment (Other)

Waiting list

Active Comparator

Waiting list and standard treatment (ADHD treatment as usual)

干预措施: Waiting list (Behavioral)

Waiting list

Active Comparator

Waiting list and standard treatment (ADHD treatment as usual)

干预措施: Standard treatment (Other)

结局指标

主要结局

Change in patient satisfaction

时间窗: Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks)

Measured with a modified version of the Client Satisfaction Questionnaire (CSQ-8). The scale consists of 8 items measured on a scale from 1 to 4. A sum score between 8 and 32 indicate the level of satisfaction with services provided.

Change in general self-efficacy

时间窗: Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks)

Measured with General Self-Efficacy Scale (GSE-6), a short-form measure of self-efficacy. Self-efficacy is regarded as a protective factor in adapting to stress and chronic illness. The scale consists of 6 items, measured on a 4-point scale, with a possible range of 6-24.

次要结局

  • Change in ADHD-related symptoms (ASRS)(Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks))
  • Change in ADHD-related symptoms (SCL-9)(Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks))
  • Change in ADHD-related quality of life(Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验